How much is Curevo Vaccine worth in 2026?

Curevo Vaccine has a current valuation of N/A based on their Later Stage VC round and secondary market data.

How much funding has Curevo Vaccine raised?

Curevo Vaccine has raised $206.2M in total funding across 3 funding rounds.

Curevo Vaccine

Drug DiscoveryWebsite

Curevo Vaccine valuation and funding history | Last updated: March 6, 2025 | 3 funding rounds

Current Valuation

N/A

As of March 6, 2025

Total Funding Raised

$206.2M

Across 3 rounds

Last Round

Later Stage VC

$110.0M

Last Funding

Mar 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
March 6, 2025	Later Stage VC (Series B)	$110.0M	N/A	-
November 16, 2022	Later Stage VC (Series A1)	$26.0M	N/A	-
February 10, 2022	Later Stage VC (Series A)	$60.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Curevo Vaccine is currently valued at N/A as of March 6, 2025. The company has raised a total of $206.2M in funding across 3 funding rounds.

Track Curevo Vaccine Valuation Updates

Get notified when Curevo Vaccine raises new funding or valuation changes

Explore More Data

Detailed analysis for Curevo Vaccine

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Curevo Vaccine's valuation history, funding rounds, and growth metrics.

No credit card required

What is Curevo Vaccine Worth in 2026?

Curevo Vaccine is a leading private company in the Drug Discovery sector. Track Curevo Vaccine's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Curevo Vaccine Valuation is Determined

Private company valuations like Curevo Vaccine's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.